United States HR 5281: Drug Price Transparency in Medicaid Act of 2019

Status: Referred to the Subcommittee on Health. (as of 2019-12-04)

State: United States · Session: 116 · Bill: HR 5281

Subjects: Business records, Congressional oversight, Government information and archives, Health care costs and insurance, Home and outpatient care, Inflation and prices, Medicaid, Prescription drugs, Public contracts and procurement, Retail and wholesale trades, State and local government operations, User charges and fees

Sponsors: Earl L. "Buddy" Carter, Tony Cardenas

View United States HR 5281 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.